Catheter Precision (VTAK) announced that its previously announced 1-for-19 reverse stock split of its common stock became effective at 12:01 A.M. Eastern Time, on August 15, 2025. The Company’s common stock will continue to be traded on the NYSE American under the symbol “VTAK” and will begin trading on a split-adjusted basis when the market opens on August 15, 2025. The new CUSIP number for the Company’s common stock following the reverse stock split will be 74933X708.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VTAK:
- Catheter Precision announces first LockeT cases completed in Germany
- Catheter Precision reports Q2 revenue $212,000 vs. $93,000 last year
- Upcoming Stock Splits This Week (August 11 to August 15) – Stay Invested
- Catheter Precision: Heart Hospital completes 200 ablation procedures with VIVO
- Catheter Precision Approves Reverse Stock Split Plan